| H.P. Acthar Gel (repository corticotropin injection) / Mallinckrodt |
NCT01769937: Open-label Trial of Acthar Gel in Subjects With Moderate to Severe Active Systemic Lupus Erythematosus |
|
|
| Completed | 4 | 10 | US | H.P. Acthar Gel, ACTH | Fiechtner, Justus J., M.D., P.C. | Lupus Erythematosus Systemic Exacerbation | 04/13 | 04/13 | | |
NCT01888354: Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations |
|
|
| Completed | 4 | 25 | US | H.P. Acthar Gel (repository corticotropin injection), Acthar, Repository Corticotropin Injection, ACTH Gel | The University of Texas Health Science Center, Houston | Multiple Sclerosis (MS) | 08/14 | 08/14 | | |
NCT01966718: Repository Corticotropin Injection To Treat Rheumatoid Arthritis Patients Who Have Failed Three Biologic Therapies. |
|
|
| Completed | 4 | 8 | US | Repository corticotropin injection, H. P. Acthar Gel | Arthritis Treatment Center, Maryland | Rheumatoid Arthritis | 10/15 | 10/15 | | |
NCT01926054: ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis |
|
|
| Withdrawn | 4 | 0 | US | Acthar gel | Ohio State University, Mallinckrodt | SLE Glomerulonephritis Syndrome, WHO Class V | 02/18 | 02/18 | | |
NCT02382523: Acthar on Proteinuria in IgA Nephropathy Patients |
|
|
| Withdrawn | 4 | 0 | US | Acthar 80 unit injection, H.P. Acthar gel | Baylor College of Medicine | IgA Nephropathy, Proteinuria | 01/19 | 01/20 | | |
| Recruiting | 4 | 20 | US | CellCept, Mycophenolate Mofetil, ACTHar gel, ACTHar, H.P. ACTHar Gel, Repository corticotropin | Columbia University | Lupus Nephritis | 01/24 | 07/24 | | |
